Axios

Axios readers across the U.S. say the worst part of moving into separate beds is the judgment from others — but they're not losing sleep over it.

Why it matters: A little separation could be the best thing for your health — and marriage.

The Food and Drug Administration on Friday rejected a controversial treatment for post-traumatic stress disorder that combines ecstasy with psychotherapy.

Why it matters: The decision is a major blow to psychedelic therapy advocates and investors, who pressed for the MDMA-assisted therapy to become the first psychedelic treatment approved for clinical use in the United States.

• FDA asked Lykos to conduct an additional clinical trial on the therapy, per the company.